News Detail

Due to the continuing difficult market environment in the ACS – Sugar segment, a non-cash impairment loss is expected to be recognised in the AGRANA Group as part of the indication-based impairment test of assets as of the balance sheet date. The impairment is forecast to impact the assets of the ACS – Sugar segment to an extent of between € 45 and € 55 million.

The final amount of the impairment loss will be determined in the course of preparing AGRANA's consolidated financial statements for the 2025|26 financial year (balance sheet date: 28 February 2026). The forecast non-cash impairment will be reported under exceptional items and thus have a negative impact on the previous guidance for EBIT¹. At Group level, management had expected EBIT to increase significantly to a range of around € 45 million to € 60 million for the 2025|26 financial year prior to the impairment.

The impairment has no impact on operating profit², which is forecast to be between around € 80 million and € 85 million in the 2025|26 financial year, moderately above the previous year (2024|25: € 76.5 million). It should be noted that the economic and financial impact of the current geopolitical and economic situation on the future business performance of the AGRANA Group remains difficult to assess.

The 2025|26 annual results and the 2025|26 annual report will be published as scheduled on 12 May 2026.

^{1 Operating profit AFTER exceptional items and results of equity-accounted joint ventures
2 Operating profit BEFORE exceptional items and results of equity-accounted joint ventures}

Download Announcement